Of note, PTP1B inhibition significantly inactivates GSK-3β-suppressing, amyloid β (Aβ)-induced tau phosphorylation and ameliorates spatial learning and memory in an animal model of AD (Kanno et al., 2016). Here, MAPT is linked to Alzheimer disease.